Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
CarParts.com Posts 5 Percent Sales Gain
Key PointsRevenue (GAAP) rose 5% year over year to $151.9 million in Q2 FY2025 but missed analyst expectations for both GAAP EPS and revenue.Earnings per share (GAAP) were ($0.23), widening from the prior-year quarter and falling short of GAAP estimates.No guidance provided as the company continues ...
The Motley Fool
Wed, Aug 13
Lyra Therapeutics Posts 85% Q2 Loss Drop
Key PointsGAAP EPS loss of $5.51 was less negative than analyst estimates for Q2 2025.GAAP revenue missed expectations at $0.18 million for Q2 2025, down from $0.598 million (GAAP) in Q2 2024 year over year and below estimates for the second quarter.Positive LYR-210 clinical trial results position t...
The Motley Fool
Wed, Aug 13
SmartKem Reports 20 Percent Sales Drop
Key PointsRevenue (GAAP) fell 20% to $32 thousand for Q2 2025 compared to $40 thousand for the same period in 2024, remaining at early-stage, pre-commercial levels.Operating expenses rose 56.7% to $4.7 million for Q2 2025 compared to $3.0 million for the same period in 2024, driven mainly by increas...
The Motley Fool
Wed, Aug 13
Japan's Orion Beer Preparing To Go Public As Early As September, Bloomberg News Says
Aug 13 (Reuters) - JAPAN'S ORION BEER PREPARING TO GO PUBLIC AS EARLY AS SEPTEMBER, BLOOMBERG NEWS SAYSSource text: [ID:]Further company coverage: [ ]
Reuters
Wed, Aug 13
DiaMedica Posts Narrower Loss in Q2
Key PointsDiaMedica Therapeutics (NASDAQ:DMAC) reported a GAAP loss per share of $(0.18) for the quarter, beating the $(0.19) GAAP analyst consensus estimate.The company shared positive interim results from the DM199 preeclampsia Phase 2 trial in July 2025, achieving all pre-specified safety and eff...
The Motley Fool
Wed, Aug 13
HK Movers | HK's Biotech Shares Soar. CANbridge up 29%; Ab&B Bio-Tech up 26%; Abbisko up 7%
Hong Kong’s biotech stocks rose on Wednesday.CANbridge rose 29%; Ab&B Bio-Tech rose 26%; Abbisko soared 7%; WuXi XDC rose 6%; Asymchem, JOINN rose 5%.Ab&B Bio-Tech soared 158% in its trading debut in Hong Kong on Monday, after retail investors flocked to the Chinese vaccine maker’s initial public of...
Tiger News
Wed, Aug 13
Team Reports 8.5 Percent Q2 Revenue Rise
Key PointsRevenue rose 8.5% to $248.0 million (GAAP) in Q2 2025, driven by 15.2% growth in Inspection and Heat Treating.Adjusted EBITDA grew 12.4% to $24.5 million, with margin improving to 9.9% of revenue.Net loss (GAAP) widened to $(4.3) million; free cash flow (non-GAAP) remained negative but imp...
The Motley Fool
Wed, Aug 13
Generation Bio Posts 81% Q2 Revenue Drop
Key PointsNet loss per share (GAAP) widened to $(3.12), missing analyst expectations by 209.47% (GAAP).Revenue (GAAP) fell sharply to $0.77 million, marking an 81.3% decrease compared to the prior year.Generation Bio has begun a strategic alternatives process and will reduce its workforce by 90%.The...
The Motley Fool
Wed, Aug 13
QuickLogic Sales Fall 10 Percent
Key PointsGAAP revenue of $3.7 million for Q2 FY2025 missed analyst estimates, down 10.0% from Q2 FY2024.Non-GAAP earnings per share were a loss of $0.09, missing consensus.Non-GAAP gross margin shrank to 31.0%, falling well below both guidance and prior-year levels.These 10 stocks could mint the ne...
The Motley Fool
Wed, Aug 13
Iridex Reports 7 Percent Q2 Revenue Gain
Key PointsTotal GAAP revenue for Q2 2025 grew 7.0% year over year to $13.6 million.GAAP gross margin narrowed to 34.5% in Q2 2025, driven by higher manufacturing costs and changes in product and geographic mix.Operating expenses fell 28% year over year in Q2 2025, contributing to a narrower GAAP net...
The Motley Fool
Wed, Aug 13
24H | DeFi Dev Stock Rockets 16%, Driven by Aggressive Solana Accumulation and Strong Staking Returns
DeFi Development Corp. shares climbed, driven by aggressive Solana accumulation and strong staking returns. The stock rose 18.30% during regular trading to $17.84 and added another 16.59% in overnight trading to $20.8.The rally followed a shareholder update detailing rapid Solana treasury growth an...
Tiger News
Wed, Aug 13
Japan's Nikkei tops 43,000 for first time ever, extends rally to sixth session
TOKYO, Aug 13 (Reuters) - Japan's Nikkei share average rose above 43,000 for the first time on Wednesday, with the broader Topix index also marking a fresh all-time high, tracking Wall Street's overnight gains and extending the rally into a sixth straight session.
Reuters
Wed, Aug 13
Asian shares rise, dollar defensive after mild inflation data
TOKYO, Aug 13 (Reuters) - Stocks in Asia climbed and the U.S. dollar was subdued on Wednesday, as data showed both resilience in major economies and the need for central banks to remain accommodative.
Reuters
Wed, Aug 13
Webtoon Reports 8 Percent Revenue Gain
Key PointsRevenue (GAAP) rose 8.5% to $348.3 million in Q2 2025, surpassing consensus by $7.7 million.Adjusted EPS reached $0.07, exceeding the analyst estimate of ($0.17).Adjusted EBITDA margin narrowed year over year from 6.3% to 2.8% despite the topline beat.These 10 stocks could mint the next wa...
The Motley Fool
Wed, Aug 13
Vicarious Surgical Narrows Loss in Q2
Key PointsEPS (Non-GAAP) loss of $2.23 per share was narrower than expected, beating analyst estimates by 10.8%.Operating expenses decreased 24%, driven by reductions across research and development, general and administrative, and sales and marketing.Cash and investments declined to $24.0 million, ...
The Motley Fool
Wed, Aug 13
Armata Posts 59 Percent Q2 Revenue Jump
Key Points- GAAP revenue was $2.2 million, outpacing the $1.38 million GAAP consensus estimate due to strong grant and award funding.- Net loss widened significantly to $0.45 per share (GAAP).- Armata achieved a major milestone with positive topline results from its Phase 1b/2a clinical trial of AP-...
The Motley Fool
Wed, Aug 13
Hyliion Posts Q2 Revenue Miss and Delay
Key PointsGAAP revenue for Q2 2025 reached $1.5 million, missing the analyst estimate of $1.6 million (GAAP) and driven entirely by research and development services for the U.S. Navy.Driven by higher research and development expenses.Hyliion halved its 2025 GAAP revenue forecast to $5–10 million an...
The Motley Fool
Wed, Aug 13
Verrica Posts Profit in Fiscal Q2
Key PointsEarnings per share of $0.25 (Non-GAAP) exceeded expectations and marked a return to profitability, boosted by a major milestone payment.Operating expenses sharply declined, with Selling, general, and administrative expenses decreased by 46% (GAAP) compared to the same period in 2024. Resea...
The Motley Fool
Wed, Aug 13
Pixelworks Posts Narrower Loss in Q2
Key PointsGAAP revenue of $8.3 million for Q2 2025 narrowly missed analyst expectations and declined 2.4% year-over-year on a GAAP basis.Non-GAAP EPS loss of ($1.00) for Q2 2025 beat estimates by 10.7%, reflecting improved cost discipline.Margin pressure persisted, but adjusted EBITDA loss and non-G...
The Motley Fool
Wed, Aug 13
Luminar Posts 5 Percent Sales Drop
Key PointsGAAP revenue for Q2 2025 was $15.6 million, missing analyst consensus estimates, reflecting a 5% year-over-year decline and underperforming the $17.3 million consensus estimate.Non-GAAP EPS loss of $(1.49) came in below expectations, missing the non-GAAP $(1.18) estimate and showing a year...
The Motley Fool
Wed, Aug 13
1
...
119
120
121
121
/
3831
122
123
...
3831
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up